About this app

VizaView is a Vizamyl™ case-based review application designed to enhance the case reading ability of trained imagers. This tool is intended for informational purposes only and is not a replacement or substitute for the required Vizamyl™ Reader Training Program. If you have clinical or scientific questions regarding the content of this app, please contact GE HealthCare at (800) 654-0118 (option 2, option 3) or via email medical.affairs@gehealthcare.com.

Latest release

What’s New

Version 2.0.0 Mar 5, 2026

• Faster study and image loading • UI and navigation improvements • Stability and performance fixes

Audience growth

Ratings growth

Steady

7-day gain +0

Ratings / day 0.0

30-day gain +0

US rating-count history

0 ratings

Baseline captured. Growth appears after the crawler observes a changed rating count.

Momentum comes from crawler snapshots for the tracked storefront. “Viral growth signal” means unusually fast recent rating gains; it is an indicator, not download data.

Price tracking